Distribution of the ?2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Histology,Pathology and Forensic Medicine
Link
http://link.springer.com/content/pdf/10.1007/BF00353892.pdf
Reference40 articles.
1. Ashcom JD, Tiller SE, Dickerson K, Cravens JL, Argraves WS, Strickland DK (1990) The human ?2-macroglobulin receptor: identification of a 420-kDa cell surface glycoprotein specific for the activated conformation of ?2-macroglobulin. J Cell Biol 110:1041?1048
2. Bauer J, Strauss S, Schreiter-Gasser U, Ganter U, Schlegel P, Witt I, Yolk B, Berger M (1991) Interleukin 6 and ?2-macroglobulin indicate an acute phase state in Alzheimer's disease cortices. FEBS Lett 285:111?114
3. Beisiegel U, Weber W, Ihrke G, Herz J, Stanley KK (1989) The LDL-receptor related protein, LRP, is an apolipoprotein-E binding protein. Nature 341:162?164
4. Brown MS, Herz J, Kowal RC, Goldstein JL (1991) The lowdensity lipoprotein receptor-related protein: double agent or decoy. Curr Opin Lipidol 2:65?72
5. Cheng CY, Grima J, Stahler MS, Guglielmotti A, Silvestrini B, Bardin CW (1990) Sertoli cell synthesizes a proteinase inhibitor, ?2-macroglobulin. Biochemistry 29:1063?1068
Cited by 380 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advances in Intrathecal Nanoparticle Delivery: Targeting the Blood–Cerebrospinal Fluid Barrier for Enhanced CNS Drug Delivery;Pharmaceuticals;2024-08-15
2. Novel insights into the multifaceted and tissue-specific roles of the endocytic receptor LRP1;Journal of Biological Chemistry;2024-08
3. Low-Density Lipoprotein Receptor-Related Protein 1 as a Potential Therapeutic Target in Alzheimer’s Disease;Pharmaceutics;2024-07-17
4. Endocrine Regulation of Microvascular Receptor—Mediated Transcytosis and Its Therapeutic Opportunities: Insights by PCSK9—Mediated Regulation;Pharmaceutics;2023-04-18
5. Molecular Mechanisms of Inhibitory Effects of Bovine Lactoferrin on Invasion of Oral Squamous Cell Carcinoma;Pharmaceutics;2023-02-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3